Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats
- PMID: 19071107
- DOI: 10.1016/j.ejphar.2008.11.031
Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats
Abstract
Levo-tetrahydropalmatine (l-THP) is an alkaloid purified from the Chinese herb corydalis and stephania and is contained in many traditional Chinese herbal preparations. Our previous studies demonstrated the ability of l-THP to inhibit locomotor stimulation and physical dependence induced by oxycodone in mice and rats. The present study was designed to evaluate effects of l-THP on reward of oxycodone using conditioned place preference assay. Oxycodone (0.32-5.0 mg/kg) induced the development of conditioned place preference in rats. Furthermore, oxycodone (2.5 mg/kg) induced the increased phosphorylation of CREB and ERK in nucleus accumbens and hippocampus, but not in prefrontal cortex. l-THP (6.25-18.50 mg/kg) per se was not able to induce conditioned place preference or conditioned place aversion. l-THP co-administered with oxycodone during the conditioning sessions partly abolished the development of oxycodone-induced conditioned place preference in rats. Furthermore, l-THP inhibited the increased phosphorylation of ERK and CREB in nucleus accumbens and hippocampus of rats. All these results suggest that l-THP can inhibit oxycodone-induced psychological dependence by affecting phosphorylation of CREB and ERK in nucleus accumbens and hippocampus of rats. Together, the present data, combined with previous finding, support the potential use of l-THP for treatment of oxycodone addiction.
Similar articles
-
l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.Future Med Chem. 2012 Feb;4(2):177-86. doi: 10.4155/fmc.11.166. Future Med Chem. 2012. PMID: 22300097 Free PMC article. Review.
-
Levo-tetrahydropalmatine attenuates the acquisition of fentanyl-induced conditioned place preference and the changes in ERK and CREB phosphorylation expression in mice.Neurosci Lett. 2021 Jun 21;756:135984. doi: 10.1016/j.neulet.2021.135984. Epub 2021 May 21. Neurosci Lett. 2021. PMID: 34029649
-
Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats.Behav Brain Res. 2017 Jan 15;317:367-373. doi: 10.1016/j.bbr.2016.10.001. Epub 2016 Oct 3. Behav Brain Res. 2017. PMID: 27713001
-
Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice.Neurosci Lett. 2020 Jan 1;714:134416. doi: 10.1016/j.neulet.2019.134416. Epub 2019 Aug 6. Neurosci Lett. 2020. PMID: 31398456
-
Levo-tetrahydropalmatine: A new potential medication for methamphetamine addiction and neurotoxicity.Exp Neurol. 2021 Oct;344:113809. doi: 10.1016/j.expneurol.2021.113809. Epub 2021 Jul 10. Exp Neurol. 2021. PMID: 34256045 Review.
Cited by
-
Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.Behav Brain Res. 2013 May 1;244:58-65. doi: 10.1016/j.bbr.2013.01.028. Epub 2013 Jan 31. Behav Brain Res. 2013. PMID: 23376703 Free PMC article.
-
An ethogram analysis of cutaneous thermal pain sensitivity and oxycodone reward-related behaviors in rats.Res Sq [Preprint]. 2023 Mar 24:rs.3.rs-2679319. doi: 10.21203/rs.3.rs-2679319/v1. Res Sq. 2023. Update in: Sci Rep. 2023 Jun 28;13(1):10482. doi: 10.1038/s41598-023-36729-6. PMID: 36993634 Free PMC article. Updated. Preprint.
-
Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in naïve rats detected at 9.4 T.Magn Reson Imaging. 2012 Feb;30(2):261-70. doi: 10.1016/j.mri.2011.09.006. Epub 2011 Nov 12. Magn Reson Imaging. 2012. PMID: 22079072 Free PMC article.
-
l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.Future Med Chem. 2012 Feb;4(2):177-86. doi: 10.4155/fmc.11.166. Future Med Chem. 2012. PMID: 22300097 Free PMC article. Review.
-
Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.Drug Alcohol Depend. 2011 Jul 1;116(1-3):72-9. doi: 10.1016/j.drugalcdep.2010.11.023. Epub 2010 Dec 31. Drug Alcohol Depend. 2011. PMID: 21196089 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous